Cite
HARVARD Citation
Jensen, M. et al. (2022). Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion. Journal of diabetes science and technology. pp. 106-112. [Online].